| Literature DB >> 30353094 |
Cheng-Hsuan Tsai1, Chen Lin2, Yi-Heng Ho3,4, Men-Tzung Lo5, Li-Yu Daisy Liu6, Chih-Ting Lin4, Jenq-Wen Huang7, Chung-Kang Peng8, Yen-Hung Lin9.
Abstract
Abdominal aorta calcification (AAC) has been associated with clinical outcomes in peritoneal dialysis (PD) patients. Heart rhythm complexity analysis has been shown to be a promising tool to predict outcomes in patients with cardiovascular disease. In this study, we aimed to analyze the association between heart rhythm complexity and AAC in PD patients. We prospectively analyzed 133 PD patients. Heart rhythm complexity including detrended fluctuation analysis and multiscale entropy was performed. In linear analysis, the patients in the higher AAC group (AAC ≥15%) had a significantly lower standard deviation of normal RR intervals, very low frequency, low frequency, high frequency and low/high frequency ratio. In non-linear analysis, DFAα1, slope 1-5, scale 5 and area 6-20 were significantly lower in the patients with higher AAC. Receiver operating characteristic curve analysis showed that DFAα1 had the greatest discriminatory power to differentiate these two groups. Multivariate logistic regression analysis showed that DFAα1 and HbA1c were significantly associated with higher AAC ratio. Adding DFAα1 significantly improved the discriminatory power of the linear parameters in both net reclassification improvement and integrated discrimination improvement models. In conclusion, DFAα1 is highly associated with AAC and a potential cardiovascular marker in PD patients.Entities:
Mesh:
Year: 2018 PMID: 30353094 PMCID: PMC6199249 DOI: 10.1038/s41598-018-33789-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical data of the patients.
| AAC <15% | AAC ≥15% | ||
|---|---|---|---|
| (N = 74) | (N = 59) | ||
| Age(Years) | 52.59 (43.44~59.47) | 58.63 (51.27~64.84) | 0.001 |
| Male, n(%) | 35 (47%) | 26 (44%) | 0.710 |
| DM, n(%) | 6 (8%) | 22 (37%) | <0.001 |
| HTN, n(%) | 61 (82%) | 52 (88%) | 0.361 |
|
| |||
| ACEI or ARB | 33 (45%) | 32 (54%) | 0.269 |
| Beta-blocker | 41 (55%) | 36 (61%) | 0.515 |
| CCB | 45 (61%) | 44 (75%) | 0.094 |
| Statin | 23 (31%) | 23 (39%) | 0.341 |
| Glucose AC, mg/dL | 91.00 (85.75~104.25) | 106.00 (92.00~140.00) | <0.001 |
| HbA1c, % | 5.30 (5.00~5.65) | 6.00 (5.30~7.00) | <0.001 |
| Creatinine, mg/dL | 11.75 (9.58~13.58) | 10.40 (8.90~12.70) | 0.037 |
| PD KT/V | 1.87 (1.67~2.05) | 1.92 (1.67~2.17) | 0.203 |
| TG, mg/dL | 151.50 (86.75~227.00) | 167.00 (101.00~240.00) | 0.377 |
| T-Chol, mg/dL | 193.00 (166.00~233.00) | 181.00 (149.00~219.00) | 0.118 |
| LDL, mg/dL | 90.50 (62.75~111.75) | 77.00 (61.00~107.00) | 0.400 |
| HDL, mg/dL | 39.00 (33.00~50.25) | 36.00 (31.00~43.00) | 0.106 |
| Na, mmol/L | 136.00 (133.00~138.00) | 136.00 (132.00~138.00) | 0.677 |
| K, mmol/L | 3.90 (3.40~4.30) | 3.80 (3.10~4.20) | 0.187 |
| Ca, mg/dL | 9.78 (9.00~10.29) | 9.52 (8.88~9.92) | 0.155 |
| P, mg/dL | 5.20 (4.80~6.30) | 5.20 (4.40~6.10) | 0.612 |
| CRP, mg/dL | 0.24 (0.10~0.79) | 0.52 (0.17~1.54) | 0.023 |
| LVEF, % | 70.53 (63.80~75.86) | 65.98 (57.71~73.54) | 0.037 |
| AAC, % | 1.32 (0.00~8.74) | 33.87(27.25~46.39) | <0.001 |
Data were presented as median (25th~75th percentile) or number (percentage). AAC = abdominal aorta calcification; DM = diabetes mellitus; HTN = hypertension; ACE-I = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; CCB = calcium channel blocker; PD = peritoneal dialysis; TG = triglycerides; T-Chol = total cholesterol; LDL = Low-density lipoprotein; HDL = high-density lipoprotein; CRP = C-reactive protein; LVEF = left ventricular ejection fraction.
Holter parameter of the patients with different AAC ratio.
| AAC <15% (N = 74) | AAC ≥15% (N = 59) | ||
|---|---|---|---|
|
| |||
| Mean RR, ms | 761.29 (660.07~843.09) | 780.67 (713.31~889.30) | 0.084 |
| SDRR, ms | 46.11 (34.28~58.12) | 33.67(23.31~46.99) | 0.001 |
| pNN50, % | 0.33 (0.08~1.77) | 0.48 (0.05~2.20) | 0.515 |
| pNN20, % | 5.85 (2.15~17.06) | 5.23 (1.34~16.44) | 0.339 |
|
| |||
| VLF | 789.84 (477.23~1459.70) | 315.90 (154.40~678.98) | <0.001 |
| LF | 152.21 (71.19~295.19) | 49.18 (17.30~147.01) | <0.001 |
| HF | 49.59 (19.05~118.55) | 29.56 (11.24~68.32) | 0.038 |
| LF/HF ratio | 2.60 (1.57~4.38) | 1.33 (0.91~2.62) | <0.001 |
|
| |||
| DFAα1 | 1.26 (1.13~1.43) | 1.00 (0.85~1.15) | <0.001 |
| DFAα2 | 1.24 (1.17~1.31) | 1.22 (1.13~1.30) | 0.853 |
|
| |||
| Slope 1–5 | 0.063 (0.0177~0.1011) | 0.023 (−0.017~0.058) | <0.001 |
| Scale 5 | 1.044 (0.898~1.197) | 0.879 (0.722~1.069) | 0.002 |
| Area 1–5 | 4.494 (3.892~5.359) | 4.22 (3.26~5.17) | 0.122 |
| Area 6–20 | 18.50 (16.21~21.59) | 16.14 (13.79~19.26) | 0.001 |
Values are median (25th~75th percentile). SDNN = standard deviation of normal RR intervals; pNN20 = percentage of the absolute change in consecutive normal RR interval exceeds 20 ms; pNN50 = percentage of the absolute change in consecutive normal RR interval exceeds 50 ms; VLF = very low frequency; LF: low frequency; HF = high frequency; DFA = detrended fluctuation analyses.
Figure 1(A, B) Analysis of the discrimination power of linear and non-linear parameters to discriminate patients with higher AAC (AAC ≥15) by receiver operating characteristic curve analysis (A) The areas under the curve of SDRR, VLF, LF, HF, LF/HF ratio were 0.663, 0.752, 0.721, 0.605 and 0.723 respectively. (B) The areas under the curve of DFAα1, slope 5, scale 5 and area 6–20 were 0.781, 0.707, 0.657 and 0.667, respectively.
Univariate and multivariate logistic regression model to predict higher abdominal aorta calcification group.
| Abnormal aorta calcification | ||||
|---|---|---|---|---|
| Univariate logistic regression | Multivariate logistic regression | |||
| β (95% C.I) | OR (95% C.I) | p value | ||
| Age | 1.058 (1.024~1.094) | 0.001 | ||
| Sex | 1.139 (0.573~2.265) | 0.710 | ||
| DM | 6.74 (2.51~18.09) | <0.001 | ||
| HTN | 1.583 (0.588~4.263) | 0.363 | ||
| Glucose, mg/dL | 1.023 (1.009~1.038) | 0.002 | ||
| HbA1c, % | 4.374 (2.339~8.181) | <0.001 | 3.497 (1.727~7.084) | 0.001 |
| PD KT/V | 1.479 (0.567~3.854) | 0.424 | ||
| Creatinine, mg/dL | 0.842 (0.734~0.966) | 0.014 | ||
| Ca, mg/dL | 0.782 (0.539~1.137) | 0.782 | ||
| P, mg/dL | 0.927 (0.698~1.233) | 0.604 | ||
| TG, mg/dL | 1.000 (0.998~1.003) | 0.633 | ||
| T-Chol, mg/dL | 0.995 (0.988~1.003) | 0.224 | ||
| LDL, mg/dL | 0.998 (0.989~1.007) | 0.696 | ||
| HDL, mg/dL | 0.974 (0.944~1.005) | 0.099 | ||
| CRP, mg/dL | 0.993 (0.842~1.171) | 0.934 | ||
| LVEF, % | 0.964 (0.933~0.996) | 0.027 | ||
| Mean RR | 1.002 (1.000~1.005) | 0.092 | ||
| SDRR | 0.976 (0.959~0.994) | 0.009 | ||
| pNN50 | 1.003 (0.966~1.042) | 0.860 | ||
| pNN20 | 0.991 (0.969~1.014) | 0.445 | ||
| VLF | 0.998 (0.998~0.999) | <0.001 | ||
| LF | 0.998 (0.997~1.000) | 0.046 | ||
| HF | 1.000 (0.999~1.002) | 0.739 | ||
| LF/HF ratio | 0.828 (0.709~0.967) | 0.017 | ||
| DFAα1 | 0.021 (0.004~0.109) | <0.001 | 0.032 (0.005~0.212) | <0.001 |
| DFAα2 | 0.600 (0.059~6.119) | 0.667 | ||
| Slope 1–5 | <0.001 (<0.001~0.001) | <0.001 | ||
| Scale 5 | 0.203 (0.059~0.705) | 0.012 | ||
| Area 1–5 | 0.844 (0.661~1.078) | 0.175 | ||
| Area 6–20 | 0.875 (0.801~0.956) | 0.003 | ||
PD = peritoneal dialysis; TG = triglycerides; T-Chol = total cholesterol; LDL = Low-density lipoprotein; HDL = high-density lipoprotein; CRP = C-reactive protein; LVEF = left ventricular ejection fraction; SDNN = standard deviation of normal RR intervals; pNN20 = percentage of the absolute change in consecutive normal RR interval exceeds 20 ms; pNN50 = percentage of the absolute change in consecutive normal RR interval exceeds 50 ms; VLF = very low frequency; LF = low frequency; HF = high frequency; DFA = detrended fluctuation analyses.
Univariate and multivariate linear regression to predict percentage (%) of abdominal aorta calcification.
| Abnormal aorta calcification | ||||
|---|---|---|---|---|
| Univariate linear regression | Multivariate linear regression | |||
| β (95% C.I) | β (95% C.I) | |||
| Age | 0.557 (0.335~0.778) | <0.001 | 0.293 (0.057~0.529) | 0.015 |
| Sex | 0.424 (−5.650~6.498) | 0.890 | ||
| DM | 9.537 (2.298~16.776) | 0.010 | ||
| HTN | 4.854 (−3.572~13.280) | 0.256 | ||
| Glucose, mg/dL | 0.193 (0.111~0.276) | <0.001 | ||
| HbA1c, % | 8.110 (5.047~11.173) | <0.001 | 4.744 (1.640~7.847) | 0.003 |
| PD KT/V | 4.508 (−3.821~12.838) | 0.286 | ||
| Creatinine, mg/dL | −1.484 (−2.585~−0.384) | 0.009 | ||
| Ca, mg/dL | −2.264 (−5.460~0.933) | 0.164 | ||
| P, mg/dL | −0.755 (−3.256~1.745) | 0.551 | ||
| TG, mg/dL | −0.032 (−0.099~0.034) | 0.336 | ||
| T-Chol, mg/dL | 0.011 (−0.007~0.028) | 0.240 | ||
| LDL, mg/dL | −0.001 (−0.08~0.077) | 0.970 | ||
| HDL, mg/dL | −0.241 (−0.502~0.019) | 0.069 | ||
| CRP, mg/dL | 0.249 (−1.201~1.700) | 0.734 | ||
| LVEF, % | −0.339 (−0.602~−0.077) | 0.012 | ||
| Mean RR | 0.011 (−0.011~0.033) | 0.320 | ||
| SDRR | −0.153 (−0.291~−0.015) | 0.030 | ||
| pNN50 | 0.119 (−0.219~0.458) | 0.486 | ||
| pNN20 | −0.039 (−0.231~0.154) | 0.693 | ||
| VLF | −0.008 (−0.012~−0.004) | <0.001 | ||
| LF | −0.01 (−0.021~0.001) | 0.081 | ||
| HF | 0.006 (−0.010~0.022) | 0.481 | ||
| LF/HF ratio | −0.982 (−1.758~−0.206) | 0.013 | 1.111 (0.161~2.060) | 0.022 |
| DFAα1 | −28.305 (−37.519~−19.091) | <0.001 | −31.189 (−44.829~-17.550) | <0.001 |
| DFAα2 | −6.613 (−27.159~13.933) | 0.525 | ||
| Slope 1–5 | −84.854 (−128.136~−41.572) | <0.001 | ||
| Scale 5 | −13.554 (−22.788~−4.32) | 0.004 | ||
| Area 1–5 | −1.816 (−3.852~0.220) | 0.08 | ||
| Area 6–20 | −1.116 (−1.777~−0.455) | 0.001 | ||
Adjusted R2:0.346. PD = peritoneal dialysis; TG = triglycerides; T-Chol = total cholesterol; LDL = Low-density lipoprotein; HDL = high-density lipoprotein; CRP = C-reactive protein; LVEF = left ventricular ejection fraction; SDNN = standard deviation of normal RR intervals; pNN20 = percentage of the absolute change in consecutive normal RR interval exceeds 20 ms; pNN50 = percentage of the absolute change in consecutive normal RR interval exceeds 50 ms; VLF = very low frequency; LF = low frequency; HF = high frequency; DFA = detrended fluctuation analyses.
AUC, NRI, and IDI models of linear parameters before and after adding DFAα1 and MSE parameters.
| Parameters | AUC | R square | NRI | NRI | IDI | IDI | |
|---|---|---|---|---|---|---|---|
| SDRR | 0.663 | 0.055 | |||||
| +DFAα1 | 0.783 | 0.213 | 0.863 | <0.001 | 0.165 | <0.001 | |
| +Slope1–5 | 0.728 | 0.157 | 0.491 | 0.004 | 0.102 | <0.001 | |
| +Area6–20 | 0.711 | 0.105 | 0.362 | 0.034 | 0.051 | 0.007 | |
| +Scale 5 | 0.705 | 0.083 | 0.186 | 0.281 | 0.031 | 0.031 | |
| VLF | 0.752 | 0.141 | |||||
| +DFAα1 | 0.795 | 0.233 | 0.477 | 0.005 | 0.082 | 0.001 | |
| +Slope1–5 | 0.773 | 0.202 | 0.383 | 0.025 | 0.052 | 0.008 | |
| +Area6–20 | 0.768 | 0.168 | 0.085 | 0.619 | 0.023 | 0.071 | |
| +Scale 5 | 0.761 | 0.153 | 0.071 | 0.680 | 0.008 | 0.278 | |
| LF | 0.721 | 0.034 | |||||
| +DFAα1 | 0.782 | 0.201 | 0.849 | <0.001 | 0.173 | <0.001 | |
| +Slope1–5 | 0.711 | 0.140 | 0.410 | 0.016 | 0.098 | <0.001 | |
| +Area6–20 | 0.693 | 0.076 | 0.261 | 0.132 | 0.040 | 0.023 | |
| +Scale 5 | 0.698 | 0.054 | 0.315 | 0.068 | 0.022 | 0.080 | |
| HF | 0.605 | 0.001 | |||||
| +DFAα1 | 0.783 | 0.198 | 0.978 | <0.001 | 0.213 | <0.001 | |
| +Slope1–5 | 0.714 | 0.151 | 0.599 | <0.001 | 0.151 | <0.001 | |
| +Area6–20 | 0.673 | 0.087 | 0.538 | 0.001 | 0.087 | <0.001 | |
| +Scale 5 | 0.670 | 0.083 | 0.497 | 0.003 | 0.083 | 0.001 | |
| LF/HF ratio | 0.722 | 0.050 | |||||
| +DFAα1 | 0.793 | 0.214 | 1.005 | <0.001 | 0.167 | <0.001 | |
| +Slope1–5 | 0.708 | 0.140 | 0.403 | 0.019 | 0.075 | 0.002 | |
| +Area6–20 | 0.709 | 0.090 | 0.234 | 0.177 | 0.038 | 0.027 | |
| +Scale 5 | 0.719 | 0.082 | 0.234 | 0.177 | 0.034 | 0.033 |
SDRR = standard deviation of normal RR intervals; VLF = very low frequency; LF = low frequency; HF = high frequency; AUC = areas under the curve; NRI = net reclassification improvement; IDI = integrated discrimination improvement; MSE = multiscale entropy; DFA = detrended fluctuation analyses.